Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Overweight women with PCOS are more likely to have excess male hormones.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Combining minoxidil with microneedling or spironolactone is more effective for female hair loss than using minoxidil alone.

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

The conclusion is that there's a need for a new conference to establish stricter guidelines for diagnosing Polycystic Ovary Syndrome (PCOS).

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Cetuximab can cause unusual hair growth and hair loss.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

The document concludes that more research is needed to understand how PRP affects the ovaries and to standardize its use in treatment.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

New treatments for PCOS are improving fertility and managing symptoms better.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

PCOS negatively affects women's quality of life, especially if not detected early.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

High BMI worsens hair growth in women with PCOS.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.